Good manufacturing practices production of human placental derived mesenchymal stem cells for therapeutic applications: focus on multiple sclerosis
CONCLUSIONS: We hope that our protocol for clinical manufacturing of PLMSCs according to GMP standards will assist researchers in isolating MSCs from placental tissue for clinical and pre-clinical applications.PMID:38551770 | DOI:10.1007/s11033-024-09372-1
Source: Mol Biol Cell - Category: Molecular Biology Authors: Ameneh Shokati Abdorreza Naser Moghadasi Andisheh Ghashghaei Mohammad Ali Sahraian Bahram Chahardouli Seyed Asadollah Mousavi Jafar Ai Mohsen Nikbakht Source Type: research
More News: Brain | Disability | Gastroschisis Repair | Genetics | Medical Ethics | Molecular Biology | Multiple Sclerosis | Neurology | Stem Cell Therapy | Stem Cells